✦ LIBER ✦
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
✍ Scribed by Armand, P.; Nagler, A.; Weller, E. A.; Devine, S. M.; Avigan, D. E.; Chen, Y.-B.; Kaminski, M. S.; Holland, H. K.; Winter, J. N.; Mason, J. R.; Fay, J. W.; Rizzieri, D. A.; Hosing, C. M.; Ball, E. D.; Uberti, J. P.; Lazarus, H. M.; Mapara, M. Y.; Gregory, S. A.; Timmerman, J. M.; Andorsky, D.; Or, R.; Waller, E. K.; Rotem-Yehudar, R.; Gordon, L. I.
- Book ID
- 121342781
- Publisher
- American Society of Clinical Oncology
- Year
- 2013
- Tongue
- English
- Weight
- 132 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0732-183X
No coin nor oath required. For personal study only.